A Study to Investigate the Safety and Efficacy of CP-690,550 in Patients With Moderate to Severe Crohn's Disease

Clinical trial NCT00615199 · COMPLETED

Trial details

NCT number: NCT00615199
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2008-01-01
Primary completion: 2009-10-01
Enrollment: 139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.